eli lilly and company zepbound

Eli Lilly plans to invest $27B to build 4 new US plants

Zepbound maker Eli Lilly announces $27 billion investment in US drug manufacturing as Trump threatens tariffs

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional $27 billion to build four new manufacturing plants in the United States, shoring up domestic manufacturing as President Donald Trump threatens new tariffs on pharmaceuticals.

New York Post on MSN · 2h

Eli Lilly plans to invest $27B to build four new US plants as tariffs loom

Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 construction workers.

The Washington Post on MSN · 49m

Eli Lilly says it will spend billions to move drug manufacturing to U.S. soil

Eli Lilly said it plans to build three new plants in the U.S. to make the key ingredients used in pharmaceuticals, part of a doubling of its investment in manufacturing.

1don MSN

Eli Lilly Cuts Price of Weight-Loss Drug Zepbound for Self-Pay Patients

Key Takeaways Eli Lilly lowered the price of two dosage levels of its weight-loss drug Zepbound for patients paying out of ...

Eli Lilly lowering price of Zepbound

Hugely popular weight loss drugs known as GLP-1's are finally getting cheaper, well at least one is, and that's the case with ...

STAT1d

Eli Lilly to lower price of Zepbound vials, offer more doses

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses ...

1don MSN

Eli Lilly cuts prices for Zepbound weight-loss drug again

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for ...

pharmaceuticalcommerce1d

Lilly Adds New Zepbound Vial Doses to the Mix

Eli Lilly and Company is unveiling its new 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, which will be available ...

Eli Lilly is making even more doses of Zepbound cheaper

Eli Lilly (LLY) is making more doses of its blockbuster weight-loss drug Zepbound available in vials and at lower prices.

Eli Lilly and Company: Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients

New 7.5 mg and 10 mg Zepbound single-dose vials now available for $499 per month via Zepbound Self Pay Journey Program 2.5 mg and 5 mg vial prices reduced INDIANAPOLIS ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results